Stmt re Theratase Ct Hearing

RNS Number:6246W
BBI Holdings PLC
15 May 2007


BBI Holdings plc ("BBI")
Theratase plc ("Theratase")

Result of Theratase Court Hearing
Admission to trading on AIM of New BBI Shares
and
Delisting of Theratase Ordinary Shares


15 May 2007


At the Theratase Court Hearing held today, the Court sanctioned the Theratase
Scheme of Arrangement under section 425 Companies Act 1985 (the "Scheme"),
pursuant to which Theratase has become a wholly owned subsidiary of BBI.

Application has been made for admission to trading on AIM of up to 15,804,437
new ordinary shares of 2.5 pence each of BBI ("New BBI Shares") to be issued in
accordance with the terms set out in the Scheme and the Admission Document and
of up to 26,740,333 existing BBI shares. Admission of the BBI Shares is expected
to become effective on 16 May 2007.

The New BBI Shares will, upon issue, rank pari passu in all respects with BBI's
existing ordinary shares. Following the issue of the New BBI Shares, BBI will
have up to 42,544,770 ordinary shares in issue.

The cancellation of the listing of the Theratase ordinary shares from the
Official List of the London Stock Exchange is expected to take effect at 8:00
a.m. on 16 May 2007.


Enquiries

BBI                                                   02920 747 232
Stephen Young

Theratase                                             020 7863 8819
Colin Anderson

Teather & Greenwood Limited                           020 7426 9000
Jeff Keating
Sindre Ottesen
Thilo Hoffmann

Teather & Greenwood Limited, which is authorised and regulated in the United
Kingdom by the Financial Services Authority, is acting exclusively for BBI and
for no one else in relation to the proposal and will not be responsible to
anyone other than BBI for providing the protections afforded to clients of
Teather & Greenwood Limited or for giving advice in relation to the proposal,
the contents of this announcement or any other arrangement or matter referred to
herein.


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END
STRILFEFESIELID